Tecan Group Ltd (TECN) - Financial and Strategic SWOT Analysis Review

Tecan Group Ltd (TECN) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Tecan Group Ltd (Tecan) is a company that provides automated laboratory instruments and solutions for basic and translational research, clinical diagnostics, and drug discovery. The company’s product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find application in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions, and synthetic biology. Its systems and components are used widely in clinical diagnostics and basic and translational research. The company operates manufacturing and research facilities in Europe and North America. Tecan is headquartered in Mannedorf, Switzerland.Tecan Group Ltd Key Recent Developments

Jun 24,2024: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division
Jun 24,2024: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division
Mar 12,2024: Tecan Reports Solid Underlying Sales Growth and an Increase In Profitability and Net Profit For Full Year 2023
Jan 08,2024: Tecan Reports Underlying Sales Growth of 6.3% For Full Year 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Tecan Group Ltd - Key Facts
Tecan Group Ltd - Key Employees
Tecan Group Ltd - Key Employee Biographies
Tecan Group Ltd - Major Products and Services
Tecan Group Ltd - History
Tecan Group Ltd - Company Statement
Tecan Group Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Tecan Group Ltd - Business Description
Business Segment: Life Sciences Business
Overview
Performance
Business Segment: Partnering Business
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Others
Performance
R&D Overview
Tecan Group Ltd - Corporate Strategy
Tecan Group Ltd - SWOT Analysis
SWOT Analysis - Overview
Tecan Group Ltd - Strengths
Tecan Group Ltd - Weaknesses
Tecan Group Ltd - Opportunities
Tecan Group Ltd - Threats
Tecan Group Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Tecan Group Ltd, Medical Equipment, Deals By Year, 2018 to YTD 2024
Tecan Group Ltd, Medical Equipment, Deals By Type, 2018 to YTD 2024
Tecan Group Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 24, 2024: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division
Jun 24, 2024: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division
Mar 12, 2024: Tecan Reports Solid Underlying Sales Growth and an Increase In Profitability and Net Profit For Full Year 2023
Jan 08, 2024: Tecan Reports Underlying Sales Growth of 6.3% For Full Year 2023
Aug 15, 2023: Tecan Reports Solid Underlying Sales Growth in the First Half of 2023 and Confirms its Outlook for Full Year 2023
Aug 08, 2023: Tecan Schedules Conference Call on August 15th to Discuss Half Year 2023 Financial Results
Jul 12, 2023: Tecan collaborates with NGS specialists to address critical needs in genomics research
Apr 18, 2023: Annual General Meeting 2023: Tecan shareholders endorse all motions proposed by the Board of Directors
Apr 11, 2023: DYNEX Technologies and Tecan partnership expands availability of ELISA immunoassays in the U.S.
Jan 25, 2023: Matthias Gillner to be proposed to the upcoming Annual General Meeting as a new member of Tecan’s Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Tecan Group Ltd, Key Facts
Tecan Group Ltd, Key Employees
Tecan Group Ltd, Key Employee Biographies
Tecan Group Ltd, Major Products and Services
Tecan Group Ltd, History
Tecan Group Ltd, Subsidiaries
Tecan Group Ltd, Key Competitors
Tecan Group Ltd, Ratios based on current share price
Tecan Group Ltd, Annual Ratios
Tecan Group Ltd, Annual Ratios (Cont...1)
Tecan Group Ltd, Annual Ratios (Cont...2)
Tecan Group Ltd, Interim Ratios
Tecan Group Ltd, Medical Equipment, Deals By Year, 2018 to YTD 2024
Tecan Group Ltd, Medical Equipment, Deals By Type, 2018 to YTD 2024
Tecan Group Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Tecan Group Ltd, Performance Chart (2019 - 2023)
Tecan Group Ltd, Ratio Charts
Tecan Group Ltd, Medical Equipment, Deals By Year, 2018 to YTD 2024
Tecan Group Ltd, Medical Equipment, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings